Shanghai MicroPort EP MedTech Co., Ltd. (SHA:688351)
19.47
-0.58 (-2.89%)
At close: Jun 10, 2025, 2:57 PM CST
SHA:688351 Revenue
Shanghai MicroPort EP MedTech had revenue of 104.10M CNY in the quarter ending March 31, 2025, with 16.77% growth. This brings the company's revenue in the last twelve months to 428.11M, up 16.90% year-over-year. In the year 2024, Shanghai MicroPort EP MedTech had annual revenue of 413.17M with 25.51% growth.
Revenue (ttm)
428.11M
Revenue Growth
+16.90%
P/S Ratio
20.71
Revenue / Employee
741.97K
Employees
577
Market Cap
8.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 413.17M | 83.97M | 25.51% |
Dec 31, 2023 | 329.19M | 68.87M | 26.46% |
Dec 31, 2022 | 260.32M | 70.30M | 36.99% |
Dec 31, 2021 | 190.03M | 48.74M | 34.50% |
Dec 31, 2020 | 141.29M | 23.85M | 20.31% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |